MENU Resources Clinical Trial Information APPROACH Open Label Study Fact Sheet (FCS) BROADEN Study Fact Sheet (FPL) More information about Akcea’s clinical trials is available at clinicaltrials.gov. For APPROACH Open Label Study (FCS) information, click here. For BROADEN Study (FPL) information, click here. Tools for Your Practice Beyond the development of potential new treatments, Akcea is committed to supporting patients and health care professionals with informational resources. For more information about FCS, please visit FCSFocus.com As part of Akcea’s commitment to FCS education and the patient perspective please use these links to view expert presentations and patient interviews: What You Need to Know About Familial Chylomicronemia Syndrome: Pathophysiology, Diagnosis, Management, and the Patient Perspective Familial Chylomicronemia Syndrome: Cause, Effect, and Solutions to Improve Patients’ Quality of Life hATTR Guide hATTR Guide provides education and resources to empower healthcare professionals to diagnose, manage and better support their patients living with hATTR amyloidosis. To learn more about supporting hATTR amyloidosis patients, including identifying the red-flag symptoms; and diagnosing, managing, and treating the disease, visit hattrguide.com or the hATTR Guide Twitter page. hATTR Compass Akcea and Ambry Genetics are partnering to offer no-cost confidential genetic testing and genetic counseling to patients suspected of having or clinically diagnosed with hATTR amyloidosis through the hATTR Compass Program. To learn more, visit hattrcompass.com. Additional resources, including a list of advocacy organizations, are available here. Medical Congresses Connect with the Akcea team at an upcoming medical meeting. United States American Academy of Neurology Los Angeles, CA April 21-27 National Lipid Association Indianapolis, IN, August 11-13 Endocrine Society Clinical Education Update Chicago, IL, September 23-25 Cardiometabolic Health Congress Boston, MA, October 4-7 Europe British Cardiovascular Society Manchester, England, June 5-7 Heart UK Warwick, England, July 5-7 European Society of Cardiology Barcelona, Spain, August 26-30 British Endocrine Society Harrogate, England, November 6-8 Asia International Society of Amyloidosis Kumamoto, Japan, March 26-29 Careers | Privacy Policy | Terms of Use | Contact | Compliance Governance Documents Akcea Therapeutics 22 Boston Wharf Road, 9th Floor, Boston MA 02210 (617) 207-0202 info@akceatx.com © 2021, all rights reserved Akcea Therapeutics has been acquired by Ionis Pharmaceuticals. For continued news and information about Akcea Therapeutics, please visit ionispharma.com. You are being redirected, please wait. If you have not been redirected in 30 seconds, please click the button below. Go to ionispharma.com